Cargando…
Vaccines for an influenza pandemic: scientific and political challenges
So far, most published results from clinical trials using various avian influenza virus vaccine formulations have been disappointing. Should the pandemic strike, we still do not have the ability to provide an efficacious pandemic vaccine in time and in sufficient quantities for the world. The H5N1 e...
Autor principal: | Haaheim, Lars R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634554/ https://www.ncbi.nlm.nih.gov/pubmed/19432635 http://dx.doi.org/10.1111/j.1750-2659.2007.00011.x |
Ejemplares similares
-
Pandemic Influenza Vaccines – The Challenges
por: Haaheim, Lars R., et al.
Publicado: (2009) -
Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1–3, 2010
por: Haaheim, Lars R., et al.
Publicado: (2011) -
Influenza: the virus and prophylaxis with inactivated influenza vaccine in “at risk” groups, including COPD patients
por: Hovden, Arnt-Ove, et al.
Publicado: (2007) -
The next influenza pandemic: lessons from Hong Kong, 1997.
por: Snacken, R, et al.
Publicado: (1999) -
A cell‐based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models
por: Cox, Rebecca J., et al.
Publicado: (2009)